Literature DB >> 4584156

Effects of mode of management on plasma chlorpromazine in psychiatric patients.

L Rivera-Calimlim, L Castañeda, L Lasagna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4584156     DOI： 10.1002/cpt1973146978

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  28 in total

1.  Arrhythmias and inhibition of noradrenaline uptake caused by tricyclic antidepressants and chlorpromazine on the isolated perfused rabbit heart.

Authors:  N Barth; M Manns; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Gastric emptying and drug absorption.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

3.  The management of neuroleptic-induced CNS effects.

Authors:  B F Hoffman; M V Seeman
Journal:  Can Fam Physician       Date:  1981-10       Impact factor: 3.275

Review 4.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 5.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

Review 6.  Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.

Authors:  R L Parsons
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

7.  A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF.

Authors:  G Alfredsson; B Wode-Helgodt; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

8.  Clinical pharmacokinetic studies of perphenazine.

Authors:  C Eggert Hansen; T Rosted Christensen; J Elley; L Bolvig Hansen; P Kragh-Sorensen; N E Larsen; J Naestoft; E F Hvidberg
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

9.  Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man.

Authors:  S Loga; S Curry; M Lader
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

10.  The effect on paracetamol absorption of stimulation and blockade of beta-adrenoceptors.

Authors:  R A Clark; C D Holdsworth; M R Rees; P J Howlett
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.